| 2024-02-13 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,352 0.0014% | $132.89 | $179,674 | +2.66% | |
| 2024-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 980 0.0009% | $134.20 | $131,519 | +1.66% | |
| 2024-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,600 0.0016% | $142.20 | $227,522 | -4.54% | |
| 2024-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,541 0.0016% | $140.70 | $216,813 | -1.96% | |
| 2024-01-02 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 75,000 0.0763% | $131.47 | $9.86M | +4.1% | |
| 2023-08-21 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 2,132 0.0022% | $107.41 | $228,993 | +22.37% | |
| 2023-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 980 0.001% | $103.99 | $101,910 | +0.32% | |
| 2023-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 14,424 0.0147% | $102.40 | $1.48M | +0.86% | |
| 2023-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,600 0.0017% | $105.64 | $169,028 | -0.39% | |
| 2023-01-31 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,541 0.0016% | $109.98 | $169,486 | -5.7% | |
| 2022-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 980 0.001% | $79.67 | $78,079 | +28.58% | |
| 2022-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 5,900 0.0062% | $80.77 | $476,549 | +26.82% | |
| 2022-01-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 28,266 0.0305% | $85.50 | $2.42M | +16.88% | |
| 2021-02-08 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 3,693 0.0039% | $116.85 | $431,518 | -19.67% | |
| 2021-02-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 2,677 0.0028% | $114.00 | $305,184 | -18.56% | |
| 2020-11-12 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 2,257 0.0024% | $90.73 | $204,770 | +6.08% | |
| 2020-08-05 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 2,257 0.0024% | $118.87 | $268,286 | -17.85% | |
| 2020-04-24 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,934 0.0021% | $99.47 | $192,377 | +6.23% | |
| 2020-02-07 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,623 0.0017% | $103.33 | $167,710 | -1.41% | |
| 2020-02-06 | Sale | Neurocrine Biosciences, Inc. NBIX | Chief Business Development Off | 1,000 0.0011% | $101.41 | $101,413 | -0.23% |